{
    "code": "10000670",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000670",
    "time": "2020-01-24 03:07:40",
    "許可證字號": "衛署菌疫輸字第000670號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/06\/11",
    "發證日期": "90\/06\/11",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000067005",
    "中文品名": "惠爾血添　Ｍ３００",
    "英文品名": "FILGRASTIM INJECTION M300,300&#181;g\/0.7ML",
    "適應症": "１．動員造血幹細胞至周邊血中、２．促進造血幹細胞移植時嗜中性白血球數的增加、３．癌症化學療法所引起之嗜中性白血球減少症、４．骨髓發育不良症候群的嗜中性白血球缺乏症、５．先天性、特異性嗜中性白血球缺乏症。",
    "劑型": "270注射劑",
    "包裝": "每盒10安瓿",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1902001100  台灣協和麒麟股份有限公司",
        "申請商地址": "台北市中山區中山北路二段44號14樓",
        "主製造廠": ""
    },
    "CCC號列": "30049020007 血液代用品與血漿代用品及基因重組製劑Substitutes of blood, substitutes of plasma and preparations  of gennetic recombinants",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FJP9444000  Nipro Pharma Corporation Ise Plant",
            "製造廠廠址": "647-240, Ureshinotengeji-cho, Matsusaka-shi, Mie 515-2302, Japan",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "成品製造廠"
        },
        {
            "製造廠名稱": "FJP9458900  KYOWA KIRIN CO., LTD. TAKASAKI PLANT",
            "製造廠廠址": "100-1 HAGIWARA-MACHI, TAKASAKISHI, GUNMAN, JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "原料藥製造廠"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1002000500",
            "成分名稱": "FILGRASTIM",
            "含量描述": "",
            "含量": "300.0000000000",
            "單位": "ug"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "[藥物外觀圖檔] Filgrastim M300_2018MAY-107-05-22(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000670&Seq=003&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "惠爾血添-仿單 201902修訂-108-08-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000670&Seq=013&Type=9"
        },
        {
            "title": "[外盒圖檔] Filgrastim M300_2018MAY-107-05-22(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000670&Seq=005&Type=8"
        },
        {
            "title": "Filgrastim injection M300 外盒標籤-(ch)-106-12-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000670&Seq=004&Type=8"
        }
    ]
}